A traditional Chinese medicine composition and a preparation thereof, and in particular, a micro drop pill. The traditional Chinese medicine composition comprises 50.0% to 99.9% of salvia miltiorrhiza and Panax notoginseng extract and 0.1% to 50.0% of borneol (by weight percentage). The salvia miltiorrhiza and Panax notoginseng extract comprises the following components (by weight percentage): salvianic acid A: salvianolic acid T: protocatechuic aldehyde: salvianolic acid D: rosmarinic acid: salvianolic acid B: salvianolic acid A: Notoginsenoside R1: ginsenoside Rg1: ginsenoside Re: ginsenoside Rb1: ginsenoside Rd: dihydrotanshinoneI: tanshinone I: cryptotanshinone: tanshinone IIΑ = (2-5): (0.5-1.9): (1.1-3): (0.2-1.2): (0.2-1): (0.5-2): (0.5-2): (0.2-1): (1.5-4): (0.1-0.5): (1-3.9): (0.1-1): (0.01-0.05): (0.05-0.1): (0.02-0.1): (0.1-0.5). A preparation method for the micro drop pill comprises vibration dropping, air cooling, and the like. The method can be used to manufacture drop pills, coated drop pills, and drop pill capsules with a high drug loading capacity. The composition has an effect of treating acute myocardial ischemia and acute myocardial infarction.La présente invention concerne une composition de médecine traditionnelle chinoise, son procédé de préparation, en particulier un micro-comprimé lingual. La composition de médecine chinoise traditionnelle comprend de 50,0 % à 99,9 % de lextrait de salvia miltiorrhiza et de panax notoginseng et de 0,1 % à 50,0 % de bornéol (pourcentage en poids). Lextrait de salvia miltiorrhiza et de Panax notoginseng comprend les composants suivants (pourcentage en poids) acide salvianique A acide salvianolique T aldéhyde protocatéchuique acide salvianolique D acide rosmarinique acide salvianolique B acide salvianolique A Notoginsénoside R1 ginsénoside Rg1 ginsénoside Re ginsénoside Rb1 ginsénoside Rd dihydrotanshinone I tanshinone I cryptotanshinone tanshinone IIΑ = (2-5): (0,5-1,9): (1,1-3): (0,2-1,2): (0,2
